The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 332:1791-1792 June 29, 1995 Number 26
NextNext

Methotrexate for Chronic Diseases in Adults

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Weinblatt, M. E.
To the Editor: Weinblatt discussed the use of methotrexate for chronic diseases in adults (Feb. 2 issue).1 Although folic acid is helpful in reducing the toxic effects of methotrexate therapy,2 its expanded use may have an unintended consequence.

In large doses, folic acid can correct the megaloblastic anemia associated with vitamin B12 deficiency without correcting — and potentially even aggravating — the neurologic abnormalities associated with this deficiency.3 The coexistence of vitamin B12 deficiency and rheumatoid arthritis has been reported.4 In patients with Crohn's disease and ileal involvement, vitamin B12 deficiency is not uncommon.5

With the increased use of methotrexate . . . [Full Text of this Article]

References




HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.